Introduction
Nikkomycins, peptidyl nucleoside antibiotics produced by Streptomyces spp. (Dahn et al., 1976) , are strong inhibitors of chitin synthase (UDP-2-acetamido-2-deoxy-D-glucose : chitin 4-~-acetamidodeoxy-~glucosyl-transferase, EC 2.4.1 .16) in the pathogenic fungus Candida albicans (McCarthy et al., 1985) . Since this enzyme does not exist in mammalian cells, nikkomycins are considered as promising potential antifungals of low toxicity for mammals. Unfortunately, their antifungal efficacy, studied in vivo in an animal model, was rather low (Becker et al., 1988) . Chitin synthase is localized in the cytoplasmic membrane, which in fungi contains a large amount of ergosterol. Several effective antifungal drugs, including synthetic azole derivatives, are inhibitors of ergosterol biosynthesis (Saag & Dismukes, 1988) . It has been reported that chitin synthesis is affected by polyene macrolides 198 1 ), cerulenin and sodium butyrate (Braun et al., 1987) , i.e. by compounds altering membrane fluidity. Previously azole antifungals were shown to cause the uncoordinated synthesis and irregular distribution of chitin in C. albicans (Vanden Bossche, 1985) and some other fungi (Marichal et al., 1984; Kerkenaar & Barug, 1984) . On the Transport studies. Yeast cells from overnight cultures were washed with sterile water and suspended in YNBG medium at lo6 cells ml-I. In some experiments antifungal azoles were added at this stage. Cell suspensions were incubated for 3 h at 37 "C with shaking (100 r.p.m.). Then the cells were harvested, washed with 50 mM-potassium phosphate buffer, pH 7-2, and suspended in the same buffer containing 1 % (w/v) glucose, in 50 ml flasks. Antifungal agents and nikkomycin or model peptides were added and flasks were incubated with shaking (100 r.p.m.), at 37 "C. Peptide uptake was determined using 2,4,6-trinitrobenzene sulphonate (TNBS), as described previously (Milewski et al., 1988) . In some experiments, cells were preincubated with azole antifungals before the determination of nikkomycin uptake.
Formation of spheroplasts.
Cells from the early exponential growth phase were harvested and washed twice with saline. Wet cells (200 mg) were suspended in 5 ml 50 mM-Tris buffer, pH 8.9, containing 5 mM-EDTA and 50 mM-dithiothreitol, and incubated for 30 min at 30 "C with gentle shaking. The cells were then harvested, washed with 50 mwpotassium phosphate buffer, pH 6.0, and suspended in 5 ml of the same buffer containing 0.6 M-KCI as an osmotic stabilizer. Lyticase (1 mg) dissolved in a minimal amount of phosphate buffer was added and the suspension was incubated at 37 "C with occasional shaking. Formation of spheroplasts was assessed microscopically by the observation of lysis in hypotonic solution. Usually 99 % conversion was achieved after 0.5 h incubation. Spheroplasts were washed twice with stabilizing buffer and suspended in a minimal amount of the same buffer. [ I 4Clglucose into cell wall polysaccharides of intact cells or regenerating spheroplasts. Intact cells from the exponential phase of growth or freshly prepared spheroplasts were suspended in 0.1 M-Tris/HCl buffer, pH 7.2, containing 0.5 M-M~SO, and 5 mwglucose. Each flask contained a known concentration of cells (about lo8 cells ml-l), 0.2 MBq [14C] glucose, and azole antifungals at appropriate concentrations, in 40 ml medium. Incubation was carried out at 37 "C for 3 h. At hourly intervals, 10 ml samples of cell suspensions were withdrawn. Cells were centrifuged (1000 g, 10 min) and the pellet was washed twice with 20ml portions of unlabelled medium and once with Tris/HCl buffer. The distribution of 14C-label into the various polysaccharide fractions was studied using a slight modification of the method of Gopal et al. (1984) . Pellets were extracted with 1 M-NaOH at 90°C for 1 h. Mannoproteins were precipitated with Fehling's solution (0 "C, 18 h), and then dissolved in 1 ml 0.1 M-potassium phosphate buffer, pH 6.0. Alkali-insoluble fractions were suspended in 2 ml portions of 0.1 M-potassium phosphate buffer, pH 6.0, and divided into two equal parts. One part was treated with 1 mg lyticase, the other with I mg chitinase. After incubation at 37 "C for 12 h, the insoluble residues were removed by centrifuging and the supernatants were analysed for radioactivity.
Incorporation of 4C-label from
Determination of chitin content. Cells were incubated with nikkomycin or/and azole antifungals in YNBG liquid medium at 37 "C with shaking (100 r.p.m.). Samples of 3 ml were withdrawn from the incubation mixtures, and cells were harvested and washed with phosphate buffered saline (PBS). Pellets were suspended in 1 ml PBS containing Calcofluor white, 100 pg m1-I. The suspensions were incubated at 37 "C for 5 min. Then cells were harvested, washed twice with PBS and suspended in PBS to OD660 =0.1. Fluorescence associated with cell suspensions was measured with a Perkin Elmer luminescence spectrometer LS 5B. Excitation was at 365 nm and band pass was at 420 nm. Fluorescence of each sample was corrected by the reference measurement of the ground fluorescence associated with samples treated as above excluding staining with Calcofluor white.
Glucose uptake into intact cells and spheroplasts was determined essentially as described by Gopal et al. (1984) .
Synergistic action of nikkomycin with azole antifungals
Two representative isobolograms, shown in Fig. 1 , demonstrate a synergistic action between nikkomycin X/Z and azole antifungals on C. albicans strains. Isobolograms for other strains and combinations were similar (data not shown). Nevertheless, some differences were observed. FIC indexes, calculated for each strain and each combination, are summarized in Table 1 . Only in two cases was an additive effect observed (FIC = 1.0). The combination of nikkomycin and tioconazole seemed to be more effective than the other two tested.
The synergistic action of nikkomycin with azole derivatives was confirmed in growth-inhibition studies (Fig. 2) . In the presence of tioconazole, 0-1 pg ml-l, in combination with nikkomycin X/Z, 0.1 pg ml-l, growth of C. albicans was inhibited by 50% after 6 h incubation. Alone, these agents affected fungal growth by no more than 10%.
Influence of azole antgungals on nikkomycin transport
In order to find an explanation for the observed synergism, the effect of azoles on nikkomycin transport was studied. Table 2 contains results of transport rate determinations performed for nikkomycin and some model peptides. None of the three azoles tested, when added simultaneously with nikkomycin or model peptides, affected their transport rates (data not shown). A slight effect was observed only when cells were preincubated with azoles before transport determination. It may be noteworthy that whereas nikkomycin transport rate was slightly enhanced, the model peptides were transported with lower rates. Table 2 . Efect of azole antifungals on the transport of nikkomycin and model peptides by C . albicans ATCC 26278
Cells from overnight culture were washed and suspended in YNBG modified medium (lo6 cells ml-I). Cells were preincubated in this medium in the presence of azole antifungals (4 h, 37 "C). Then cells were harvested and suspended in potassium phosphate buffer containing 1% glucose (lo8 cells ml-I). Nikkomycin or model peptides were added simultaneously with a new portion of azole antifungals and the rate of peptide transport was determined using the TNBS method. Transport rates are expressed as nmol peptide taken up by 1 mg cells (dry weight) per minute. Values are the means of three independent experiments f SD. Egect of azole antifungals on cell wall polysaccharide biosy n t hesis C. albicans cells were incubated with antifungal azoles and labelled with [ 14C]glucose. Cell walls were isolated and fractionated as described in Methods. The identity of soluble fractions obtained after treatment with lyticase and chitinase was confirmed by paper chromatography. N-Acetyl-D-glucosamine and N,N'-diacetylchitobiose were the only products of degradation by chitinase. Lyticase released only D-glucose and short glucose oligomers. Therefore, the respective fractions were assigned as chitin and alkali-insoluble glucan. S . Milewski, F. Mignini and E . Borowski Fluconazole, tioconazole and ketoconazole strongly inhibited incorporation of 4C-label from [ 14C]glucose into chitin of intact C. albicans cells. The time-course of incorporation of radioactivity from the labelled glucose in the presence of fluconazole or tioconazole is shown in Fig. 3 (a-c) . Results for ketoconazole were practically the same as those for tioconazole. Incorporation of the labelled precursor into glucan and mannoproteins was markedly affected only at high azole concentrations, whereas at the lowest concentrations, the only effect observed was a partial inhibition of incorporation into chitin. The time-course of incorporation into chitin in the presence of fluconazole at 1000 pg ml-l or 100 pg ml-l was exactly the same. It should be also pointed out that because of the high cell density, growth was practically not affected (data not shown), in spite of the reduced incorporation of the radioactive label into chitin. A similar effect was observed when incorporation of labelled glucose into cell wall polysaccharides of regenerating spheroplasts was studied (Table 3) . However, in this case, high concentrations of fluconazole and tioconazole caused practically complete inhibition of incorporation into chitin and glucan. At lower concentrations, only incorporation of radioactive label into chitin was still strongly reduced.
Cells treated with antifungal azoles and/or nikkomycin X/Z were stained with Calcofluor white and the total fluorescence after excitation by UV light was measured in order to determine the relative chitin content ( Table  4) . A significant decrease of fluorescence was observed for tioconazole-treated cells as well as for the combination of tioconazole, 0.1 pg ml-l, and nikkomycin, 0.1 pg ml-l. The lowest level of fluorescence was observed after 3 h incubation with tioconazole. However, after 24 h treatment with tioconazole, cells showed a substantial increase in fluorescence. On the other hand, the level of fluorescence associated with cells treated with tioconazole plus nikkomycin was still low. It should be noted that the results obtained for cells incubated for 24 h were poorly reproducible (high SD values). Ketoconazole, fluconazole and tioconazole did not show any effect on glucose uptake into intact cells or regenerating spheroplasts (data not shown).
Discussion
The phenomenon of synergism often enables reduction of effective doses of chemotherapeutic agents. This possibility is especially noteworthy in chemotherapy of systemic fungal infections since some of the antifungal agents used in clinical practice are relatively toxic and show many adverse effects (Walsh & Pizzo, 1988) .
In this paper we report that synthetic azole derivatives in combination with the antibiotic nikkomycin are stronger inhibitors of C. albicans growth than each of the agents alone. Although this phenomenon may be of some importance for possible chemotherapeutic applications, we were especially interested in explaining the biochemical basis of the observed synergism.
There are three generally accepted basic mechanisms of synergistic activity (Neuman, 1980; Klastersky, 1984) : increase by one agent of the permeability of the cell wall and membranes to the second agent; inhibition of enzymes able to degrade the second agent ; and double blocking by the two components of successive steps in the metabolic sequence. The second mechanism seems to be unlikely in the present study, because none of the anti fungal agents studied here inhibits any degrading enzyme. The potentiation of nikkomycin uptake by azoles was surprisingly low. This result was unexpected, because nikkomycin is transported into fungal cells by a peptide transport system (Yadan et al., 1984) . Since peptide permeases are localized in the cytoplasmic membrane, one might expect substantial alterations to their activity as a secondary effect of the action of antifungal azoles. However, our results indicate that even long-term treatment of C. albicans cells with ergosterol biosynthesis inhibitors alters the activity and substrate specificity of peptide permeases only slightly. Surarit & Shepherd (1987) reported that azole antifungals were able to inhibit chitin synthase in a plasma membrane fraction, but detailed data were not given.
Since azole antifungals are A1 4-lanosterol demethylase inhibitors, it seems likely that changes in membrane fluidity connected with the replacement of ergosterol with lanosterol may affect chitin synthase activity. This mechanism was suggested by other authors as an explanation for the effect of azoles on plasma membrane enzymes, especially those involved in the biosynthesis of the fungal cell wall (Odds et al., 1985) . However, in the present study, whereas the incorporation of 14C label into chitin of intact cells was strongly inhibited by azoles, the respective incorporation into alkali-insoluble glucan and mannoprotein was only slightly affected. The azoleinduced inhibition of chitin biosynthesis was confirmed by the fluorimetric determination of chitin content and studies on incorporation of 14C label into cell wall of regenerating sphetoplasts, which were previously reported to synthesize much more chitin than intact cells (Elorza et al., 1983) . The complete inhibition of incorporation into chitin and glucan of regenerating spheroplasts, observed for a high concentration of tioconazole (80 pg ml-l), should have been connected with a known phenomenon of direct membrane damage S . Milewski, F. Mignini and E. Borowski (Ansehn & Nilsson, 1984) . The lack of the cell wall in spheroplasts makes the cell membrane easily accessible for azole derivatives and enables direct interactions. All the above results seem to be inconsistent with previous reports given by many authors who observed irregular distribution of chitin and unbalanced (possibly enhanced) biosynthesis of this polysaccharide as a result of the action of antifungal azoles. The phenomenon was demonstrated by fluorescence microscopy (Kerkenaar & Barug, 1984; Marichal et al., 1984; Vanden Bossche, 1985) and by the determination of the chitin:total carbohydrate ratio (Vanden Bossche, 1985) . It should be noted, however, that all these previous observations were made after 24 h treatment of fungal cells with azole derivatives. In the present study we also noted enhanced chitin content after such a long treatment. Nevertheless, other evidence presented in this work indicates the selective inhibition of chitin biosynthesis as an initial result of the action of antifungal azoles on C. albicans cells. This effect was also observed even when cell growth was not affected. Nicholas & Kerridge (1989) reported that azole antifungals could inhibit ergosterol biosynthesis without any growth inhibition. In this respect, although a direct interaction of azole antifungals with chitin synthase cannot be excluded, it is more likely that azole antifungals at subinhibitory concentrations prevent the formation of chitosomes (small vesicles delivering molecules of chitin synthase to the forming septum : Bartnicki-Garcia, 198 1). The chitosomal membrane contains more ergosterol than the cytoplasmic membrane (Hernandez et al., 1981) , thus the lack of this sterol should affect chitosome formation. The postulated mechanism of the combined action of azole antifungals with nikkomycin might be considered as a sequential blockade of chitin biosynthesis. However, in cells surviving long-term treatment with low doses of azole antifungals the biosynthesis of chitin synthase molecules may be unaffected. In this case, irregular, uncoordinated chitin deposition would be an obvious consequence. This phenomenon may be also disadvantageous for candidal cells, as was shown previously in studies on the combined action of nikkomycin with papulacandin B, the inhibitor of P(1-3)glucan synthase. In that case the synergistic effect was observed although papulacandin B alone caused enhanced chitin deposition (Hector & Braun, 1986) .
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